Next Article in Journal
Cleaning the Label of Cured Meat; Effect of the Replacement of Nitrates/Nitrites on Nutrients Bioaccessibility, Peptides Formation, and Cellular Toxicity of In Vitro Digested Salami
Next Article in Special Issue
Green Synthesis of Carbon Nanoparticles (CNPs) from Biomass for Biomedical Applications
Previous Article in Journal
Discovery of New Phenylacetone Monooxygenase Variants for the Development of Substituted Indigoids through Biocatalysis
Previous Article in Special Issue
Non-Functionalized Gold Nanoparticles Inhibit Human Papillomavirus (HPV) Infection
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Graphene Quantum Dots Modified Upconversion Nanoparticles for Photodynamic Therapy

School of Science, China University of Geosciences (Beijing), Beijing 100083, China
*
Authors to whom correspondence should be addressed.
These authors contributed equally to this work.
Int. J. Mol. Sci. 2022, 23(20), 12558; https://doi.org/10.3390/ijms232012558
Submission received: 3 October 2022 / Revised: 16 October 2022 / Accepted: 18 October 2022 / Published: 19 October 2022
(This article belongs to the Special Issue Functional Nanomaterials for Healthcare)

Abstract

:
Photodynamic therapy (PDT), as a novel technique, has been extensively employed in cancer treatment by utilizing reactive oxygen species (ROS) to kill malignant cells. However, most photosensitizers (PSs) are short of ROS yield and affect the therapeutic effect of PDT. Thus, there is a substantial demand for the development of novel PSs for PDT to advance its clinical translation. In this study, we put forward a new strategy for PS synthesis via modifying graphene quantum dots (GQDs) on the surface of rare-earth elements doped upconversion nanoparticles (UCNPs) to produce UCNPs@GQDs with core-shell structure. This new type of PSs combined the merits of UCNPs and GQDs and produced ROS efficiently under near-infrared light excitation to trigger the PDT process. UCNPs@GQDs exhibited high biocompatibility and obvious concentration-dependent PDT efficiency, shedding light on nanomaterials-based PDT development.

1. Introduction

Photodynamic therapy (PDT) is an emerging cancer treatment method combining light, oxygen, and a photosensitizer (PS) to produce highly cytotoxic reactive oxygen species (ROS) that cause cancer cell death [1,2,3]. Two kinds of mechanisms (type I and II) are involved in the PDT process. In most cases, the type II mechanism needs to transform ground-state triplet oxygen (3O2) into highly reactive singlet oxygen (1O2) and is limited by the concentration of O2. Different from the type II route, the type I process takes place through either electron or hydrogen atom abstraction by exciting PSs from the substrate and performs well even under low O2 conditions [4,5]. Compared with conventional cancer therapy methods, PDT is superior in minimal side effects, low cumulative toxicity, precise targeting therapy with no damage to neighboring normal tissues, and long-term therapeutic effect [6]; however, inherent shortages of PDT impede its clinical translation, such as limited depth of light penetration, inefficient ROS generation, and lacking ideal PSs.
In recent years, nanoparticles (NPs) have been tried to be used as PSs toward solving the associated problems with PDT [7,8]. Upconversion nanoparticles (UCNPs) are a new type of optical nanomaterials composed of rare earth elements with low bandgap and featured with narrow emission bands and excellent photostability [9,10,11,12]. The upconversion luminescence of UCNPs provides an alternative way to overcome the existing drawbacks of PDT [13]. The near-infrared (NIR) excitation light of UCNPs is a transparent window in tissue and permits deep tissue penetration. Besides that, due to the adjustable doped ratio of rare earth elements, the intramolecular charge transfer can be realized via excited state absorption and energy transfer, which provides a promising pathway for electron transfer aiding ROS generation [14,15]. Meanwhile, versatile nanocomposites based on UCNPs can be designed due to their easy surface functionalization and show great potential for PDT applications.
In this work, UCNPs (NaYF4:Yb/Er) were modified with graphene quantum dots (GQDs) to obtain a composite (UCNPs@GQDs) which was used as PSs for PDT in the NIR therapeutic window. The surface of UCNPs was activated by the N-doped GQDs, which were synthesized by using folic acid (FA) as a carbon source. GQDs were selected as the modification agent due to their rich valence band could stabilize electrons/holes [16]. GQDs displayed some advantages which were beneficial for PDT, such as excellent photoluminescent features, corrosion resistance, high water solubility, high photo/pH-stability, in vitro and in vivo biocompatibility, and efficient ROS generation [17,18]. Here, the ROS generation performance was dramatically promoted in the composite of UCNPs@GQDs due to the up-convert energy transition and dexter excitation transfer (DET), which was identified by photoluminescence (PL) spectra. ROS production was accompanied by the chemical adsorption of oxygen, which was reduced by the photo-induced electrons to be O2•− and then was oxidized to be 1O2 by holes. Significantly, upon protonation, the charge separation was further increased due to the improved light absorption capacity and limited electron–hole recombination. Combined with the excellent charge separation and promoted oxygen diffusion and ROS release, the modified UCNPs led to excellent PDT performance through the type I mechanism.

2. Results

2.1. Characterization of UCNPs@GQDs

The morphology of UCNPs@GQDs was examined by transmission electron microscopy (TEM) and scanning electron microscope (SEM) (Figure 1a and Figure S1b). UCNPs@GQDs exhibited a core-shell structure, and the thickness of the shell was about 1.8 nm. All of the nanoparticles displayed similar shapes and equal sizes. UCNPs lattice was observed, and the width of lattice fringes was 0.51 nm which was consistent with the characteristic packing of UCNPs demonstrating the core-shell structure of UCNPs@GQDs. Elemental mapping images in Figure S2 also proved this and showed that the distribution of elements C, N, and O was consistent with that of elements Y and Yb. The X-ray diffraction (XRD) patterns of the synthesized GQDs, UCNPs, and UCNPs@GQDs are presented in Figure 1b. XRD profile of UCNPs clearly revealed their crystallization of the α phase (JCPDS 77-2042) [19]. The obvious peak located at 25° in the XRD pattern of GQDs arose from the 002-lattice plane [20]. The XRD pattern of UCNPs@GQDs demonstrated their well-crystallized structure, which was the same as that of UCNPs. The zeta potential of GQDs, UCNPs, and UCNPs@GQDs was detected in pH = 7 aqueous medium and is shown in Figure 1c. It exhibited that the zeta potential of GQDs was opposite to that of UCNPs. That was why the two particles were mutually combined to form a composite. Meanwhile, the decrease in zeta potential for UCNPs@GQDs proved the successful loading of GQDs. The detailed bond structure on the UCNPs@GQDs surface was confirmed by X-ray photoelectron spectroscopy (XPS) spectra (Figure 1d–f). In the high-resolution XPS spectra of C 1s of UCNPs@GQDs, C=C (284.2 eV), C-O (284.9 eV), and C=O (288.4 eV) peaks were observed and demonstrated the existence of GQDs on the surface of UCNPs. The high-resolution XPS spectra of Y 3d also confirmed this result. In addition to the presence of the Y-F (161.2 eV) peak of NaYF4, Y-O (159.2 eV) peak also presented with higher strength, possibly because the oxygen-containing functional groups existing on the surface of GQDs filled within lattice defects of NaYF4. As a result, DET may occur between GQDs and UCNPs. The convergence of the XPS profiles of C 1s and Y 3d was good, demonstrating the credibility of these data (Figure S3).
As one kind of carbon dot, GQDs also have excitation wavelength-dependent PL emission [21]. GQDs emission exhibited a red shift as the excitation light shifted to a longer wavelength (Figure 2a). The strongest emission of GQDs was located at 412 nm when the excitation wavelength was 350 nm. Such properties were inherited in UCNPs@GQDs PL spectra, which also had the red-shift effect and gave the maximum emission at the wavelength of 382 nm excited by the light of 320 nm (Figure 2b). The PL emission of UCNPs@GQDs gives them the potential to be fluorescent imaging materials. The decrease in emission intensity of UCNPs@GQDs was referred to as the result of the blocking of n-π* transitions of oxygen-containing functional groups on the surface of GQDs. Based on XPS spectra, the oxygen-containing functional groups partially filled in the lattice defects of UCNPs, making some n-electrons participate in forming feedback bonds, which weakened the PL emission of UCNPs@GQDs. These results indirectly proved the successful formation of the core-shell structure in UCNPs@GQDs. Meanwhile, under the irradiation of 980 nm laser, the main emission peaks of the UCNPs located at 407, 525, 543, and 657 nm and were attributed to 2H9/24I15/2, 2H11/24I15/2, 4S3/24I15/2, 4F9/24I15/2 transitions of Er3+ ions, respectively. GQDs gave a broad UV-Vis absorption band which centered at ~310 nm but had no overlap with the emission of UCNPs, indicating there was no Förster resonance energy transfer between UCNPs and GQDs (Figure 2c) [22,23]. The emission spectra of UCNPs@GQDs, UCNPs, and GQDs were detected through exciting by a 980 nm laser to explore the possible energy transfer mechanism between the UCNPs and GQDs. Compared with the emission spectrum of UCNPs, the main emission peak located at 543 nm significantly dropped as well as a new emission peak appeared at 354 nm in the emission spectrum of UCNPs@GQDs (Figure 2d). The new emission at the short wavelength availed electron ionization in high-energy states to generate ROS in an aqueous environment. The emission intensity of UCNPs@GQDs was dramatically quenched by GQDs, giving a promise for cytotoxic 1O2 generation [24]. The inset photograph in Figure 2d also clearly showed that the upconversion emission of UCNPs was partially quenched by the incorporated GQDs. Pure GQDs gave no upconversion emission irradiated by the 980 nm laser. As a result, the synthesized UCNPs@GQDs can be used as a potential PDT agent activated by NIR lights.

2.2. In Vitro ROS Detection for UCNPs@GQDs

·OH and 1O2 are two kinds of ROS that are cytotoxic to cancer cells and can kill them by activating cell apoptosis or necrosis by attacking organic compounds encountered in the PDT process. Room-temperature electron paramagnetic resonance (EPR) spectra were collected to detect ·OH generated by UCNPs@GQDs under the irradiation of a 980 nm laser. DMPO was utilized as a specific detection reagent for ·OH to examine the variation of ·OH generation with the irradiation time. In Figure 3a, the characteristic 1:2:2:1 EPR signals (marked with red asterisk symbols) were assigned to DMPO-·OH and confirmed the generation of ·OH, which increased with the time of laser irradiation. In this system, DMPO was oxidized by 1O2 to be 5,5-dimethyl-2-oxopyrroline-1-oxyl (DMPOX), which gave triplet signals in EPR spectra (marked with black square symbols), indicating the existence of 1O2 in this system. Meanwhile, 1O2 generation was further detected by two specific fluorescent probes, Singlet Oxygen Sensor Green (SOSG) and 1,3-diphenylisobenzofuran (DPBF). SOSG was sensitive to 1O2, while it did not react with ·OH or superoxide. SOSG reacted with 1O2 to give green FL, which became more intense with the increasing amount of 1O2. As shown in Figure 3b and Figure S4a,b, the FL intensity of SOSG rapidly increased with the presence of both UCNPs and UCNPs@GQDs under the 980 nm laser irradiation. Compared with the FL intensity curve of UCNPs, the slope of the curve of UCNPs@GQDs was larger, indicating more 1O2 generation induced by UCNPs@GQDs. Then, 1O2 production of UCNPs@GQDs was investigated by DPBF, which was a commercial fluorescent probe and irreversibly reacted with 1O2 to be 1,2-dibenzoylbenzene (DBB) (Figure S4c). The conjugated structure in DBB was broken and resulted in the decrease of absorbance of DPBF. Upon irradiation by a 980 nm laser, the absorbance intensities were decreased by UCNPs and UCNPs@GQDs, while GQDs brought no effect on the absorbance intensity (Figure 3c and Figure S3d). Both UCNPs and UCNPs@GQDs induced 1O2 generation. The irradiation time was longer, and the decrease in the absorbance intensity was faster (Figure S4e,f). The slope of the curves in Figure 3c represented the efficiency of 1O2 generation. It was obvious that the efficiency of 1O2 generation induced by UCNPs@GQDs was higher than that of UCNPs. All these results demonstrated the capability of UCNPs@GQDs for ROS generation, which is promising for their application in PDT.

2.3. PDT Assessment for UCNPs@GQDs

Before PDT assessment, the cytotoxicity of UCNPs@GQDs was evaluated by Live/Dead assay kit to make sure whether their biocompatibility was appropriate for PDT tests. A series of UCNPs@GQDs concentrations ranging from 0.16 to 1600 μg∙mL−1 were assessed in order to test all the concentrations used in PDT tests. Without NIR laser irradiation, the cells treated by UCNPs@GQDs exhibited high cell viability, which was above 80% at the concentration even up to 1600 μg∙mL−1 suggesting the good biocompatibility of the synthesized UCNPs@GQDs (Figure 4a and Figure S5a). UCNPs@GQDs-treated cells followed by NIR laser irradiation had an apparently declined cell viability compared with the dark group demonstrating UCNPs@GQDs had perfect PDT efficacy for tumor cells (Figure 4b and Figure S5b). The data in Figure 4b and Figure S4c also indicate that UCNPs@GQDs displayed poor toxicity to the cells under dark conditions.
High ROS generation is indispensable for a PS and plays an important role in the PDT process. The amount of ROS is kept low in a normal intracellular microenvironment of cancer cells and easily neutralized by in vivo antioxidants. PS can break this balance by inducing a large amount of ROS generation and initiating cell apoptosis. Dihydroethidium (DHE) was used as a specific FL probe to detect intracellular ROS generation induced by UCNPs@GQDs under NIR laser irradiation. Intracellular DHE gave blue FL emission (λex = 370 nm) before illumination and reacted with ROS to give red FL emission (λex = 535 nm) after illumination. As shown in Figure 5, the red FL of ROS augmented with the increase in UCNPs@GQDs concentration, and the results were consistent with the data on cell viability.

3. Discussion

Here, GQDs-modified UCNPs were used as a novel PS in the PDT process induced by NIR light. The composite UCNPs@GQDs were facilely prepared and exhibited excellent biocompatibility. Cytotoxic ROS was efficiently generated upon NIR light irradiation. As a result, this work provides a novel paradigm with highly integrated functionalities, which exhibits excellent prospects not only for imaging-guided PDT but also encourages us to further explore new types of multifunctional NPs for biomedical applications.

4. Materials and Methods

4.1. Reagents and Materials

FA, oleic acid, 1-octadecene, and Tris-HCl buffer were all purchased from Sigma-Aldrich Chemical Co. Ltd. (St. Louis, MO, USA). Ethanol (99.7%) and sodium hydroxide were purchased from Sinopharm Chemical Reagent Co. Ltd. (Shanghai, China). Hydrochloric acid (HCl), methanol (MeOH), and cyclohexane were supplied by Beijing Chemical Reagent Co. Ltd. (Beijing, China). SOSG, DPBF, and DHE were purchased from Leyan reagent Co. Ltd. All chemical reagents were used as received without further purification.

4.2. Apparatus

High-resolution TEM (HRTEM) images were recorded by a JEOL-1400 transmission electron microscope (JEOL, Tokyo, Japan). The PL spectra were performed on an Agilent Cary Eclipse spectrofluorometer (F-7000, Hitachi, Japan). The silt width was set as 5 nm. The voltage of the photomultiplier tube (PMT) was controlled to be 700 V. UV-vis absorption spectra were collected on a Perki-nElmer Lambda 950 spectrophotometer. SEM images were taken on a field emission scanning electron microscope (FESEM, Carl Zeiss AG, Germany). XRD spectra were collected on Bruker D8 diffractometer with the Cu Kα radiation. XPS was measured by an X-ray photoelectron spectrometry (AXIS SUPRA, SHIMADZU, Japan). EPR spectra were measured on a Bruker E500 spectrometer.

4.3. Material Synthesis

4.3.1. Synthesis of GQDs

GQDs were synthesized according to a previous method with some modifications [25]. Then, 10 mg FA was dissolved in 15 mL of deionized water. It was uniformly dispersed under ultrasonic conditions and then transferred into a 25 mL Teflon-lined stainless-steel autoclave. The FA solution was heated at 240 °C for 6 h. After cooling to room temperature, a dark brown liquid was obtained and centrifuged at 12,000 rpm for 10 min to remove the sediment. The product was freeze-dried and stored at room temperature for further use. The obtained N-doped GQDs were sphere-like NPs of about 2–3 nm size (Figure S1a) and consisting of nitrogen and functional groups of –OH, –NH2, and –COOH.

4.3.2. Synthesis of UCNPs

The coprecipitation method was adopted to synthesize the UCNPs (NaYF4:Yb/Er) following a recipe from the literature with some slight modifications [26]. Then, 3.2 mL Y(OAc)3 (0.2 M), 720 μL Yb(OAc)3 (0.2 M), 80 μL Er(OAc)3 (0.2 M), and 6 mL oleic acid were mixed well in a 100 mL two-neck flask, and the reaction was carried out at 150 °C for 30 min under vigorous stirring to evaporate the water. Then, 14 mL1-octadecene was added to the mixture, and the reaction was kept at 150 °C for another 30 min. After that, the temperature of the mixture was cooled to ~50 °C. Then, 4 mL NaOH solution (0.5 M, dissolved in MeOH) was mixed with 8 mL NH4F solution (0.4 M) and quickly added into the reaction system, which was kept at 50 °C for 30 min. Then, the temperature of the system was warmed up to 100 °C and held for 20 min to remove MeOH. After three cycles of pumping and charging with high-purity nitrogen, the reaction was carried out at 290 °C for 2 h under nitrogen protection. After the reaction was completed and cooled to room temperature, ethanol, cyclohexane, 2 M HCl:ethanol (V:V = 1:1), and deionized water were used to clean the reactant by centrifugation, and the solid was collected for subsequent use.

4.3.3. Synthesis of UCNPs@GQDs

In total, 4 mL GQDs (1 mg·mL−1) were uniformly mixed with 12.8 mg UCNPs and then sonicated for 20 min. Subsequently, the mixture was loaded into a Teflon line stainless steel autoclave and reacted at 80 °C for 6 h. After the reaction, it was cooled to room temperature. The product was mixed with deionized water and centrifuged twice at 12,000 rpm for 15 min. The solid was collected and dispersed in 0.05 M Tris-HCl buffer (pH = 7.4) for further use.

4.4. Assessment of 1O2 Generation

SOSG was used as a 1O2 indicator to evaluate the 1O2 generation [27]. SOSG reacted with 1O2 to give bright green fluorescence (FL) (λexem = 504/525 nm). GQDs, UCNPs, or UCNPs@GQDs were suspended in 2 mL water at the concentration of 500 μg·mL−1 in the presence of 10 μM SOSG. The mixed suspension was exposed to laser irradiation (0.8 W·cm−2, 980 nm) for 0, 10, 20, 30, 60, 90, 120, and 180 s, and the FL at different time points was measured with a fluorimeter. Further, 1O2 generation was monitored by DPBF via UV-vis spectroscopy [28]. DPBF (100 μg·mL−1) was dispersed in GQDs, UCNPs, or UCNPs@GQDs solutions. Then, the mixed solution was irradiated by a 980 nm laser with the power of 0.8 W·cm−2. The change of absorption of DPBF at 412 nm was recorded over time.

4.5. PDT Tests

4.5.1. Biocompatibility of UCNPs@GQDs

HeLa cells were seeded at a density of 1 × 104 cells per well in a 96-well plate and cultured at 37 °C for 24 h in a 5% CO2 environment. After that, the culture medium was replaced by a series of UCNPs@GQDs solutions (dissolved in Tris-HCl) with concentration gradients (1.6 × 10−4, 1.6 × 10−3, 1.6 × 10−2, 0.16, and 1.6 mg·mL−1) and the cells continued to be cultured for 24 h. Afterwards, cell apoptosis was analyzed by staining cells with a Live/Dead assay kit (Calcein-AM/EthD-1, Invitrogen, CA, USA). The stained cells were observed by an FL confocal microscope, and the data were analyzed by the program Image-Pro Plus 6.0. Three independent experiments were carried out with the same concentration gradients of UCNPs@GQDs solutions.

4.5.2. Cell Apoptosis Assays

HeLa cells were seeded at a density of 1 × 104 cells per well in a 96-well plate and cultured at 37 °C for 24 h in a 5% CO2 environment. The 96-well plate is numbered from top to bottom and from left to right. The No. 1–3 rows on the 96-well plate were used for PDT tests, and the No. 4–6 rows were used as the control groups without NIR laser irradiation. After 24 h cell culture, UCNPs@GQDs solutions were infused into the wells in rows 1–6. The wells in rows No. 7 and 8 were infused with blank Tris-HCl buffer solution. Cells were incubated with UCNPs@GQDs for 6 h. After that, a 980 nm laser beam with the power of 0.8 W/cm2 was used to irradiate the cells in No. 1–3 and 7 rows for 20 min, and the irradiation was stopped for 1 min every 1 min. After another 48-h incubation, the cells were stained by a Live/Dead assay kit and observed by an FL confocal microscope. For intercellular ROS detection, the cells were stained by DHE and observed by an FL confocal microscope. The data were analyzed by the program Image-Pro Plus 6.0.

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/ijms232012558/s1.

Author Contributions

Y.L. and Y.W. equally contributed to this work. Methodology, data analysis, and draft writing, Y.L.; methodology and data analysis, Y.W.; writing—review and editing, H.S.; supervision, project administration, and funding acquisition, J.W. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by the National Natural Science Foundation of China (Nos. 21874120 and 22001240), Beijing Natural Science Foundation (No. 2222022), and the Fundamental Research Funds for the Central Universities (Nos. 2652019112 and 2652018004).

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Karges, J. Clinical development of metal complexes as photosensitizers for photodynamic therapy of cancer. Angew. Chem. Int. Edit. 2022, 61, e202112236. [Google Scholar] [CrossRef] [PubMed]
  2. Pham, T.C.; Nguyen, V.N.; Choi, Y.; Lee, S.; Yoon, J. Recent strategies to develop innovative photosensitizers for enhanced photodynamic therapy. Chem. Rev. 2021, 121, 13454–13619. [Google Scholar] [CrossRef] [PubMed]
  3. Yang, Y.; Zeng, Z.; Almatrafi, E.; Huang, D.; Zhang, C.; Xiong, W.; Cheng, M.; Zhou, C.; Wang, W.; Song, B.; et al. Core-shell structured nanoparticles for photodynamic therapy-based cancer treatment and related imaging. Coord. Chem. Rev. 2022, 458, 214427. [Google Scholar] [CrossRef]
  4. Tabrizi, P.F.; Wennige, S.; Berneburg, M.; Maisch, T. Susceptibility of soda- and sodb-deficient escherichia coli mutant towards antimicrobial photodynamic inactivation via the type i-mechanism of action. Photoch. Photobio. Sci. 2018, 17, 352–362. [Google Scholar] [CrossRef] [Green Version]
  5. Huang, L.; Zhao, S.; Wu, J.; Yu, L.; Singh, N.; Yang, K.; Lan, M.; Wang, P.; Kim, J.S. Photodynamic therapy for hypoxic tumors: Advances and perspectives. Coord. Chem. Rev. 2021, 438, 213888. [Google Scholar] [CrossRef]
  6. Dolmans, D.E.J.G.; Fukumura, D.; Jain, R.K. Photodynamic therapy for cancer. Nat. Rev. Cancer 2003, 3, 380–387. [Google Scholar] [CrossRef]
  7. Choi, J.; Sun, I.C.; Hwang, H.S.; Yoon, H.Y.; Kim, K. Light-triggered photodynamic nanomedicines for overcoming localized therapeutic efficacy in cancer treatment. Adv. Drug Deliver. Rev. 2022, 186, 114344. [Google Scholar] [CrossRef]
  8. Zhou, S.Y.; Li, D.D.; Lee, C.; Xie, J. Nanoparticle phototherapy in the era of cancer immunotherapy. Trends Chem. 2020, 2, 1082–1095. [Google Scholar] [CrossRef]
  9. Han, S.Y.; Yi, Z.G.; Zhang, J.B.; Gu, Q.F.; Liang, L.L.; Qin, X.; Xu, J.H.; Wu, Y.M.; Xu, H.; Rao, A.; et al. Photon upconversion through triplet exciton-mediated energy relay. Nat. Commun. 2021, 12, 3704. [Google Scholar] [CrossRef]
  10. Han, S.Y.; Deng, R.R.; Gu, Q.F.; Ni, L.M.; Huynh, U.; Zhang, J.B.; Yi, Z.G.; Zhao, B.D.; Tamura, H.; Pershin, A.; et al. Lanthanide-doped inorganic nanoparticles turn molecular triplet excitons bright. Nature 2020, 587, 594. [Google Scholar] [CrossRef]
  11. Yi, Z.G.; Luo, Z.C.; Qin, X.; Chen, Q.S.; Liu, X.G. Lanthanide-activated nanoparticles: A toolbox for bioimaging, therapeutics, and neuromodulation. Acc. Chem. Res. 2020, 53, 2692–2704. [Google Scholar] [CrossRef] [PubMed]
  12. Zheng, K.Z.; Loh, K.Y.; Wang, Y.; Chen, Q.S.; Fan, J.Y.; Jung, T.; Nam, S.H.; Suh, Y.D.; Liu, X.G. Recent advances in upconversion nanocrystals: Expanding the kaleidoscopic toolbox for emerging applications. Nano Today 2019, 29, 100797. [Google Scholar] [CrossRef]
  13. Liu, Y.; Meng, X.; Bu, W. Upconversion-based photodynamic cancer therapy. Coord. Chem. Rev. 2019, 379, 82–98. [Google Scholar] [CrossRef]
  14. Li, Y.; Jia, D.L.; Ren, W.; Shi, F.; Liu, C.H. A versatile photoinduced electron transfer-based upconversion fluorescent biosensing platform for the detection of disease biomarkers and nerve agent. Adv. Funct. Mater. 2019, 29, 1903191. [Google Scholar] [CrossRef]
  15. Xu, H.; Han, S.Y.; Deng, R.R.; Su, Q.Q.; Wei, Y.; Tang, Y.A.; Qin, X.; Liu, X.G. Anomalous upconversion amplification induced by surface reconstruction in lanthanide sublattices. Nat. Photonics 2021, 15, 732–737. [Google Scholar] [CrossRef]
  16. Yan, Y.; Gong, J.; Chen, J.; Zeng, Z.; Huang, W.; Pu, K.; Liu, J.; Chen, P. Recent advances on graphene quantum dots: From chemistry and physics to applications. Adv. Mater. 2019, 31, 1808283. [Google Scholar] [CrossRef] [PubMed]
  17. Zhang, X.L.; Wei, C.B.; Li, Y.; Yu, D.S. Shining luminescent graphene quantum dots: Synthesis, physicochemical properties, and biomedical applications. TrAC Trends Anal. Chem. 2019, 116, 109–121. [Google Scholar] [CrossRef]
  18. Chung, S.; Revia, R.A.; Zhang, M.Q. Graphene quantum dots and their applications in bioimaging, biosensing, and therapy. Adv. Mater. 2021, 33, 1904362. [Google Scholar] [CrossRef]
  19. Vukovic, M.; Dinic, I.; Jardim, P.; Marković, S.; Veselinović, L.; Nikolić, M.; Mancic, L. The low-temperature sonochemical synthesis of up-converting β NaYF4:Yb,Er mesocrystals. Adv. Powder Technol. 2022, 33, 103403. [Google Scholar] [CrossRef]
  20. Kumar, S.; Ojha, A.K.; Ahmed, B.; Kumar, A.; Das, J.; Materny, A. Tunable (violet to green) emission by high-yield graphene quantum dots and exploiting its unique properties towards sun-light-driven photocatalysis and supercapacitor electrode materials. Mater. Today Commun. 2017, 11, 76–86. [Google Scholar] [CrossRef]
  21. Ghosh, S.; Chizhik, A.M.; Karedla, N.; Dekaliuk, M.O.; Gregor, I.; Schuhmann, H.; Seibt, M.; Bodensiek, K.; Schaap, I.A.T.; Schulz, O.; et al. Photoluminescence of carbon nanodots: Dipole emission centers and electron–phonon coupling. Nano Lett. 2014, 14, 5656–5661. [Google Scholar] [CrossRef] [PubMed]
  22. Wu, L.; Huang, C.; Emery, B.P.; Sedgwick, A.C.; Bull, S.D.; He, X.; Tian, H.; Yoon, J.; Sessler, J.L.; James, T.D. Förster resonance energy transfer (fret)-based small-molecule sensors and imaging agents. Chem. Soc. Rev. 2020, 49, 5110–5139. [Google Scholar] [CrossRef] [PubMed]
  23. Zu, F.; Yan, F.; Bai, Z.; Xu, J.; Wang, Y.; Huang, Y.; Zhou, X. The quenching of the fluorescence of carbon dots: A review on mechanisms and applications. Microchim. Acta 2017, 184, 1899–1914. [Google Scholar] [CrossRef]
  24. Zhang, D.; Wen, L.; Huang, R.; Wang, H.; Hu, X.; Xing, D. Mitochondrial specific photodynamic therapy by rare-earth nanoparticles mediated near-infrared graphene quantum dots. Biomaterials 2018, 153, 14–26. [Google Scholar] [CrossRef] [PubMed]
  25. Liu, H.F.; Li, Z.H.; Sun, Y.Q.; Geng, X.; Hu, Y.L.; Meng, H.M.; Ge, J.; Qu, L.B. Synthesis of luminescent carbon dots with ultrahigh quantum yield and inherent folate receptor-positive cancer cell targetability. Sci. Rep. 2018, 8, 1086. [Google Scholar] [CrossRef] [Green Version]
  26. Wang, F.; Deng, R.; Liu, X. Preparation of core-shell nagdf4 nanoparticles doped with luminescent lanthanide ions to be used as upconversion-based probes. Nat. Protoc. 2014, 9, 1634–1644. [Google Scholar] [CrossRef]
  27. Hou, W.Y.; Yuan, Y.; Sun, Z.Z.; Guo, S.X.; Dong, H.W.; Wu, C.F. Ratiometric fluorescent detection of intracellular singlet oxygen by semiconducting polymer dots. Anal. Chem. 2018, 90, 14629–14634. [Google Scholar] [CrossRef]
  28. Wang, X.H.; Yu, Y.X.; Cheng, K.; Yang, W.; Liu, Y.A.; Peng, H.S. Polylysine modified conjugated polymer nanoparticles loaded with the singlet oxygen probe 1,3-diphenylisobenzofuran and the photosensitizer indocyanine green for use in fluorometric sensing and in photodynamic therapy. Microchim. Acta 2019, 186, 842. [Google Scholar] [CrossRef]
Figure 1. Characterization of UCNPs@GQDs. (a) HRTEM image of UCNPs@GQDs. The inset was the lattice fringes of UCNPs. (b) XRD pattern of UCNPs@GQDs. (c) Zeta potential of GQDs, UCNPs, and UCNPs@GQDs. (d) XPS survey spectrum of UCNPs@GQDs. (e) High-resolution C 1s XPS profiles of UCNPs@GQDs. (f) High-resolution Y 3d XPS profiles of UCNPs@GQDs.
Figure 1. Characterization of UCNPs@GQDs. (a) HRTEM image of UCNPs@GQDs. The inset was the lattice fringes of UCNPs. (b) XRD pattern of UCNPs@GQDs. (c) Zeta potential of GQDs, UCNPs, and UCNPs@GQDs. (d) XPS survey spectrum of UCNPs@GQDs. (e) High-resolution C 1s XPS profiles of UCNPs@GQDs. (f) High-resolution Y 3d XPS profiles of UCNPs@GQDs.
Ijms 23 12558 g001
Figure 2. Optical properties of UCNPs@GQDs. (a) PL spectra of GQDs detecting with different excitation wavelengths. (b) PL spectra of UCNPs@GQDs detecting with different excitation wavelengths. (c) The spectral overlap of GQDs absorption and UCNPs emission (λex = 980 nm). (d) Upconversion luminescence spectra of UCNPs@GQDs, UCNPs, and GQDs (λex = 980 nm). The insert is the photograph of UCNPs@GQDs and UCNPs upon 980 nm laser irradiation.
Figure 2. Optical properties of UCNPs@GQDs. (a) PL spectra of GQDs detecting with different excitation wavelengths. (b) PL spectra of UCNPs@GQDs detecting with different excitation wavelengths. (c) The spectral overlap of GQDs absorption and UCNPs emission (λex = 980 nm). (d) Upconversion luminescence spectra of UCNPs@GQDs, UCNPs, and GQDs (λex = 980 nm). The insert is the photograph of UCNPs@GQDs and UCNPs upon 980 nm laser irradiation.
Ijms 23 12558 g002
Figure 3. In vitro 1O2 detection for UCNPs@GQDs. (a) EPR spectra of UCNPs@GQDs were detected under the irradiation of a 980 nm laser for different times. DMPO was used as the specific scavenger agent to detect ·OH generation. The EPR signals marked with red asterisk symbols were assigned to DMPO-·OH. The EPR signals marked with black square symbols were assigned to 1O2. (b) FL intensity curves of SOSG were detected at 525 nm upon treatment by UCNPs and UCNPs@GQDs and subsequent 980 nm laser irradiation in different time duration. (c) Absorption decay curves of DPBF were detected at 420 nm upon treatment by UCNPs@GQDs and subsequent 980 nm laser irradiation in different time duration.
Figure 3. In vitro 1O2 detection for UCNPs@GQDs. (a) EPR spectra of UCNPs@GQDs were detected under the irradiation of a 980 nm laser for different times. DMPO was used as the specific scavenger agent to detect ·OH generation. The EPR signals marked with red asterisk symbols were assigned to DMPO-·OH. The EPR signals marked with black square symbols were assigned to 1O2. (b) FL intensity curves of SOSG were detected at 525 nm upon treatment by UCNPs and UCNPs@GQDs and subsequent 980 nm laser irradiation in different time duration. (c) Absorption decay curves of DPBF were detected at 420 nm upon treatment by UCNPs@GQDs and subsequent 980 nm laser irradiation in different time duration.
Ijms 23 12558 g003
Figure 4. PDT assessment for UCNPs@GQDs. (a) Biocompatibility of UCNPs@GQDs was assessed without irradiation of a 980 nm laser. (b) Cell viability of HeLa cells treated by UCNPs@GQDs was determined by Live/Dead assay kit.
Figure 4. PDT assessment for UCNPs@GQDs. (a) Biocompatibility of UCNPs@GQDs was assessed without irradiation of a 980 nm laser. (b) Cell viability of HeLa cells treated by UCNPs@GQDs was determined by Live/Dead assay kit.
Ijms 23 12558 g004
Figure 5. Intracellular ROS detection using DHE as the specific fluorescent probe. HeLa cells were treated with different concentrations of UCNPs@GQDs and illuminated by a 980 nm laser.
Figure 5. Intracellular ROS detection using DHE as the specific fluorescent probe. HeLa cells were treated with different concentrations of UCNPs@GQDs and illuminated by a 980 nm laser.
Ijms 23 12558 g005
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Li, Y.; Wang, Y.; Shang, H.; Wu, J. Graphene Quantum Dots Modified Upconversion Nanoparticles for Photodynamic Therapy. Int. J. Mol. Sci. 2022, 23, 12558. https://doi.org/10.3390/ijms232012558

AMA Style

Li Y, Wang Y, Shang H, Wu J. Graphene Quantum Dots Modified Upconversion Nanoparticles for Photodynamic Therapy. International Journal of Molecular Sciences. 2022; 23(20):12558. https://doi.org/10.3390/ijms232012558

Chicago/Turabian Style

Li, Yuting, Yufei Wang, Hong Shang, and Jing Wu. 2022. "Graphene Quantum Dots Modified Upconversion Nanoparticles for Photodynamic Therapy" International Journal of Molecular Sciences 23, no. 20: 12558. https://doi.org/10.3390/ijms232012558

APA Style

Li, Y., Wang, Y., Shang, H., & Wu, J. (2022). Graphene Quantum Dots Modified Upconversion Nanoparticles for Photodynamic Therapy. International Journal of Molecular Sciences, 23(20), 12558. https://doi.org/10.3390/ijms232012558

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop